. . . . . . . . . . . . "a(CHEBI:thapsigargin) -> r(HGNC:DUSP1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Table 1. Genes regulated by thapsigargin according to microarray analysis in human VSMCs Gene ID \tGene Name \tCluster \tFold Change DUSP1 (MKP-1) \tMAP kinase phosphatase 1* \tHs.171695 \t1.975 DSCR1 \tDown syndrome critical region \tHs.282326 \t1.778 CYR61 \tCysteine-rich protein 61* \tHs.8867 \t1.718 FN1 \tFibronectin 1* \tHs.203717 \t1.667 GLT8D1 \tGlycosyltransferase 8 domain-containing 1 \tHs.297304 \t1.563 KLF6 \tKruppel-like factor 6 \tHs.285313 \t1.559 PLK2 \tPol-like kinase 2* \tHs.398157 \t1.553 CXCL2 \tChemokine (C-X-C motif) ligand* \tHs.75765 \t1.538 TM4SF1 \tTransmembrane 4L six family member \tHs.351316 \t1.533 GEM \tGTP-binding protein* \tHs.345139 \t1.53 FOS \tv-fos FBJ murine osteosarcoma viral oncogene homology* \tHs.25647 \t1.52 ATF3 \tActivating transcription factor 3* \tHs.460 \t1.515 Genes significantly changed by ?1.5-fold when treated for 30 min with 100 nM thapsigargin compared with no treatment. In the case of multiple probe sets, exemplar is represented. VSMCs, vascular smooth muscle cells. * Ca3+/cAMP response element (CRE)-containing consensus." . . "Selventa" . . . . "2014-07-03T14:32:55.992+02:00"^^ . . .